Technetium-99m-Tetrofosmin Myocardial Imaging in Cardiotoxicity Screening for Left-sided Breast Cancer Irradiation

Authors

  • Kiki Pistevou-gompaki Department of Radiation Oncology, Department of Radiotherapy AHEPA Hospital, HYGEIA General Hospital Athens
  • Damianos Eleftheriadis Department of Radiation Oncology, Department of Radiotherapy AHEPA Hospital, HYGEIA General Hospital Athens
  • Christos Trontzos Department of Radiation Oncology, Department of Radiotherapy AHEPA Hospital, HYGEIA General Hospital Athens
  • Michael Goutzioulis Department of Radiation Oncology, Department of Radiotherapy AHEPA Hospital, HYGEIA General Hospital Athens
  • Vassilis Kouloulias Department of Radiation Oncology, Department of Radiotherapy AHEPA Hospital, HYGEIA General Hospital Athens
  • Nikos Eleftheriadis Department of Radiation Oncology, Department of Radiotherapy AHEPA Hospital, HYGEIA General Hospital Athens
  • Ioannis Sofroniadis Department of Radiation Oncology, Department of Radiotherapy AHEPA Hospital, HYGEIA General Hospital Athens

DOI:

https://doi.org/10.1080/02841860310004698

Abstract

No Abstract Available

Downloads

Download data is not yet available.

Downloads

Published

2003-01-01

How to Cite

Pistevou-gompaki, K. ., Eleftheriadis, D. ., Trontzos, C. ., Goutzioulis, M. ., Kouloulias, V. ., Eleftheriadis, N. ., & Sofroniadis, I. . (2003). Technetium-99m-Tetrofosmin Myocardial Imaging in Cardiotoxicity Screening for Left-sided Breast Cancer Irradiation. Acta Oncologica, 42(4), 349–351. https://doi.org/10.1080/02841860310004698

Issue

Vol. 42 No. 4 (2003): Acta Oncologica

Section

Articles